Buckingham Palace confirmed on Monday that King Charles III has been diagnosed with a ‘form of cancer’ and has commenced treatment. The Palace, in its statement, did not specify the type of cancer the 75-year-old British monarch is battling, but it clarified that the cancer diagnosis is unrelated to the recent treatment he received for a benign prostate condition.
The statement from the Royal Palace further informed that during the course of the treatment, as advised by the doctors, the King will postpone his public-facing duties but will continue to undertake State business and official paperwork as usual.
The Palace’s statement reads, “During The King’s recent hospital procedure for benign prostate enlargement, a separate issue of concern was noted. Subsequent diagnostic tests have identified a form of cancer. His Majesty has today commenced a schedule of regular treatments, during which time he has been advised by doctors to postpone public-facing duties. Throughout this period, His Majesty will continue to undertake State business and official paperwork as usual.”
The statement also conveyed, “The King is grateful to his medical team for their swift intervention, made possible thanks to his recent hospital procedure. He remains wholly positive about his treatment and looks forward to returning to full public duty as soon as possible.”
As soon as the news was confirmed, UK Prime Minister Rishi Sunak, Labour leader Sir Keir Starmer, and Commons Speaker Sir Lindsay Hoyle extended their well-wishes. US President Joe Biden also expressed concern and said he will speak to King Charles III. In a post on X, Biden later said, “Navigating a cancer diagnosis, treatment, and survivorship takes hope and absolute courage. Jill and I join the people of the United Kingdom in praying that His Majesty experiences a swift and full recovery.”
It is pertinent to note that King Charles III ascended to the throne following the passing of his mother, Queen Elizabeth II, in September 2022, with his coronation taking place the subsequent May.
